Saba Capital Management, L.P.'s Form 4 filing
BlackRock Health Sciences Term Trust (BMEZ) · filed Dec 7, 2023
- Accession no.
- 0001510281-23-000617
- Filed
- Dec 7, 2023, 2:08 PM ET
- Trade date
- Dec 5-6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $6.26M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saba Capital Management, L.P.CIK 0001510281 | 10% Owner |
| Weinstein BoazCIK 0001608233 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 | Common Stock | PPurchaseAcquired | +222,737 | $14.10 | +$3,140,591.7 | 14,828,744 | Indirect | |
| Dec 6, 2023 | Common Stock | PPurchaseAcquired | +220,605 | $14.15 | +$3,121,560.75 | 15,049,349 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.